The Indian government's position remains that the United States should not take "unilateral" action when it comes to India's IPR regime. The USTR resisted considerable pressure earlier this year and kept India off the list it reserves for the world's worst IPR offenders. New Delhi wants Washington to keep making this effort, while it explains its IPR policy through bilateral working groups such as the one mentioned in the agreement between Messrs Modi and Obama. Commerce Minister Nirmala Sitharaman has also said that a comprehensive IPR policy is being worked on in India, to help settle disputes such as that with the United States. In any case, few can claim that India's IPR regime violates the multilateral Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, which actually allows very wide latitude to national policymakers. This is why most Indian IPR decisions go unchallenged in international forums. India's law is particularly strong on what New Delhi sees as safeguarding national interests - in particular, it goes an extra mile to shield the interests of local industry by utilising the many flexibilities allowed under the TRIPS. Much of the anger in the United States came following decisions in India - one by the administration and the other by the judicial system - that militated against the interest of multinational pharmaceutical companies. Yet, whatever the larger wisdom of those decisions, one things seems clear: they were not supposed to be part of a broader pattern of violation of international norms on IPR. Yet India appears to have so far signally failed to convince international business or other countries of this fact.
It is in the context of this failure to communicate that the current stand-off between New Delhi and Washington should be evaluated. Will India benefit more from its current stated stand, of non-cooperation with any investigation that does not come under the framework agreed by the two heads of government? Or will more communication reduce the chances that the USTR will come to a conclusion that harms Indian commercial and consumer interests?
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
